2 jun | 2025 Transcriptional repression of SOX2 by p53 in cancer cells regulates cell identity and migration. Lado-Fernández, P, Vilas, JM, Fernandes, T, Carneiro, C, Da Silva-Álvarez, S, Estévez-Souto, V, Pedrosa, P, González-Barcia, M, Abatti, LE, Mitchell, JA, Rivas, C, Moreno-Bueno, G , Vidal, A, Collado, M. Int J Cancer (PMID: 40456627) (doi:10.1002/ijc.35490)
27 feb | 2025 Radiotherapy resistance driven by Asparagine endopeptidase through ATR pathway modulation in breast cancer. Morillo-Huesca, M, G López-Cepero, I, Conesa-Bakkali, R, Tomé, M, Watts, C, Huertas, P, Moreno-Bueno, G , Durán, RV, Martínez-Fábregas, J. J Exp Clin Cancer Res - 44 (1) : 74 (PMID: 40012043) (doi:10.1186/s13046-025-03334-6)
4 feb | 2025 Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastases. Rodriguez-Baena, FJ, Marquez-Galera, A, Ballesteros-Martinez, P, Castillo, A, Diaz, E, Moreno-Bueno, G , Lopez-Atalaya, JP, Sanchez-Laorden, B. Cancer Cell (PMID: 39919736) (doi:10.1016/j.ccell.2025.01.008)
16 oct | 2024 Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations. Youssef, KK, Narwade, N, Arcas, A, Marquez-Galera, A, Jiménez-Castaño, R, Lopez-Blau, C, Fazilaty, H, García-Gutierrez, D, Cano, A , Galcerán, J, Moreno-Bueno, G , Lopez-Atalaya, JP, Nieto, MA. Nat Cancer (PMID: 39414946) (doi:10.1038/s43018-024-00839-5)
20 sep | 2024 Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application. Casas-Arozamena, C, Vilar, A, Cueva, J, Arias, E, Sampayo, V, Diaz, E, Oltra, SS , Moiola, CP, Cabrera, S, Cortegoso, A, Curiel, T, Abalo, A, Pamies Serrano, M, Domingo, S, Padilla-Iserte, P, Arnaez de la Cruz, M, Hernández, A, García-Pineda, V, Ruiz-Bañobre, J, López, R, Matias-Guiu, X, Colás, E, Gil-Moreno, A, Abal, M, Moreno-Bueno, G , Muinelo-Romay, L. J Exp Clin Cancer Res - 43 (1) : 264 (PMID: 39304963) (doi:10.1186/s13046-024-03158-w)
13 sep | 2024 Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors. Moreno-Moreno, E, Caniego-Casas, T, Carretero-Barrio, I, Cortés, A, Muriel, A, Domínguez-Rullán, JA, Martín-Gromaz, C, Moreno-Bueno, G , Matías-Guiu, X, Palacios, J, Pérez-Mies, B. Am J Surg Pathol (PMID: 39269025) (doi:10.1097/PAS.0000000000002308)
27 jun | 2024 Tumor-Intrinsic Perinuclear LOXL2: Prognostic Relevance and Relationship with YAP1 Activation Status in Oral Squamous Cell Carcinoma. Rodrigo, JP, Moreno-Bueno, G , Lequerica-Fernández, P, Rodríguez-Santamarta, T, Díaz, E, Prieto-Fernández, L, Álvarez-Teijeiro, S, García-Pedrero, JM, de Vicente, JC. Pathobiology (PMID: 38934185) (doi:10.1159/000539928)
18 mayo | 2024 Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management. Rosas-Alonso, R, Colmenarejo-Fernández, J, Pernía, O, Burdiel, M, Rodríguez-Antolín, C, Losantos-García, I, Rubio, T, Moreno-Velasco, R, Esteban-Rodríguez, I, Martínez-Marín, V, Yubero, P, Costa-Fraga, N, Díaz-Lagares, A, López-López, R, Díaz-Martin, E, García, JF, Sánchez, CV, Gandía-González, ML, Moreno-Bueno, G , de Castro, J, de Cáceres, II. Sci Rep - 14 (1) : 11398 (PMID: 38762534) (doi:10.1038/s41598-024-62061-8)
7 mayo | 2024 CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation. González-Martínez, S, Kajabova, VH, Pérez-Mies, B, Carretero-Barrio, I, Caniego-Casas, T, Sarrió, D , Moreno-Bueno, G , Gión, M, Perez-García, J, Cortés, J, Smolkova, B, Palacios, J. Virchows Arch (PMID: 38713384) (doi:10.1007/s00428-024-03814-8)
15 feb | 2024 TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling. Marugán, C, Sanz-Gómez, N , Ortigosa, B , Monfort-Vengut, A , Bertinetti, C , Teijo, A, González, M , Alonso de la Vega, A, Lallena, MJ, Moreno-Bueno, G , de Cárcer, G . Mol Oncol (PMID: 38357786) (doi:10.1002/1878-0261.13602)
16 ene | 2024 HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells. Morillo-Bernal, J , Pizarro-García, P , Moreno-Bueno, G , Cano, A , Mazón, MJ , Eraso, P , Portillo, F . Cancers (Basel) - 16 (2) (PMID: 38254873) (doi:10.3390/cancers16020384)
6 ene | 2024 Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation. Tundidor, I, Seijo-Vila, M, Blasco-Benito, S, Rubert-Hernández, M, Moreno-Bueno, G , Bindila, L, de la Rosa, RF, Guzmán, M, Sánchez, C, Pérez-Gómez, E . Cell Death Discov - 10 (1) : 12 (PMID: 38184644) (doi:10.1038/s41420-023-01788-1)
1 dic | 2023 Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance. Ostrowska-Lesko, M, Rajtak, A, Moreno-Bueno, G , Bobinski, M. Biochim Biophys Acta Rev Cancer - 1879 (1) : 189036 (PMID: 38042260) (doi:10.1016/j.bbcan.2023.189036)
1 dic | 2023 Structural and functional insights into GSDMB isoforms complex roles in pathogenesis. Colomo, S , Ros-Pardo, D, Oltra, SS , Gomez-Puertas, P, Sarrio, D , Moreno-Bueno, G . Cell Cycle (PMID: 38037340) (doi:10.1080/15384101.2023.2287933)
23 nov | 2023 Gasdermin-B (GSDMB) takes center stage in antibacterial defense, inflammatory diseases, and cancer. Sarrio, D , Colomo, S , Moreno-Bueno, G . FEBS J (PMID: 37997534) (doi:10.1111/febs.17018)
13 jun | 2023 Correction: Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment. Lores, S, Gámez-Chiachio, M , Cascallar, M, Ramos-Nebot, C , Hurtado, P, Alijas, S, López López, R, Piñeiro, R, Moreno-Bueno, G , de la Fuente, M. Biomater Sci - 11 (12) : 4397 (PMID: 37255382) (doi:10.1039/d3bm90029k)
13 jun | 2023 Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment. Lores, S, Gámez-Chiachio, M , Cascallar, M, Ramos-Nebot, C , Hurtado, P, Alijas, S, López López, R, Piñeiro, R, Moreno-Bueno, G , de la Fuente, M. Biomater Sci - 11 (12) : 4210-4225 (PMID: 36790445) (doi:10.1039/d2bm01456d)
30 mayo | 2023 Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer. Tundidor, I, Seijo-Vila, M, Blasco-Benito, S, Rubert-Hernández, M, Adámez, S, Andradas, C, Manzano, S, Álvarez-López, I, Sarasqueta, C, Villa-Morales, M, González-Lois, C, Ramírez-Medina, E, Almoguera, B, Sánchez-López, AJ, Bindila, L, Hamann, S, Arnold, N, Röcken, C, Heras-Murillo, I, Sancho, D, Moreno-Bueno, G , Caffarel, MM, Guzmán, M, Sánchez, C, Pérez-Gómez, E . Nat Commun - 14 (1) : 3130 (PMID: 37253733) (doi:10.1038/s41467-023-38750-9)
7 mayo | 2023 The E1a Adenoviral Gene Upregulates the Yamanaka Factors to Induce Partial Cellular Reprogramming. Mendoza, G, González-Pastor, R, Sánchez, JM, Arce-Cerezo, A, Quintanilla, M , Moreno-Bueno, G , Pujol, A, Belmar-López, C, de Martino, A, Riu, E, Rodriguez, TA, Martin-Duque, P . Cells - 12 (9) (PMID: 37174738) (doi:10.3390/cells12091338)
11 mar | 2023 Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells. Oltra, SS , Colomo, S , Sin, L , Pérez-López, M , Lázaro, S , Molina-Crespo, A , Choi, KH, Ros-Pardo, D, Martínez, L , Morales, S , González-Paramos, C , Orantes, A, Soriano, M, Hernández, A, Lluch, A, Rojo, F, Albanell, J, Gómez-Puertas, P, Ko, JK, Sarrió, D , Moreno-Bueno, G . Cell Death Differ (PMID: 36899106) (doi:10.1038/s41418-023-01143-y)
9 mar | 2023 Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases. Carretero-Barrio, I, Caniego-Casas, T, Rosas, M, Sánchez, MC, Martínez-Jáñez, N, Chiva, M, Sarrió, D , Moreno-Bueno, G , Palacios, J, Pérez-Mies, B. Cancers (Basel) - 15 (6) (PMID: 36980575) (doi:10.3390/cancers15061688)
4 nov | 2022 Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study. Garcia-Casado, Z, Oaknin, A, Mendiola, M , Alkorta-Aranburu, G, Antunez-Lopez, JR, Moreno-Bueno, G , Palacios, J, Yubero, A, Marquez, R, Gallego, A, Sanchez-Heras, AB, Lopez-Guerrero, JA, Perez-Segura, C, Barretina-Ginesta, P, Alarcon, J, Gaba, L, Marquez, A, Matito, J, Cueva, J, Palacio, I, Iglesias, M, Arcusa, A, Sanchez-Lorenzo, L, Guerra-Alia, E, Romero, I, Vivancos, A. J Pers Med - 12 (11) (PMID: 36579549) (doi:10.3390/jpm12111842)
26 sep | 2022 Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation. Gámez-Chiachio, M , Molina-Crespo, Á , Ramos-Nebot, C , Martinez-Val, J, Martinez, L , Gassner, K, Llobet, FJ, Soriano, M, Hernandez, A, Cordani, M , Bernadó-Morales, C, Diaz, E, Rojo-Sebastian, A, Triviño, JC, Sanchez, L, Rodríguez-Barrueco, R, Arribas, J, Llobet-Navás, D, Sarrió, D , Moreno-Bueno, G . J Exp Clin Cancer Res - 41 (1) : 285 (PMID: 36163066) (doi:10.1186/s13046-022-02497-w)
15 abr | 2022 Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma. Alonso-Nocelo, M , Ruiz-Cañas, L , Sancho, P, Görgülü, K, Alcalá, S , Pedrero, C , Vallespinos, M , López-Gil, JC , Ochando, M , García-García, E, David Trabulo, SM, Martinelli, P, Sánchez-Tomero, P , Sánchez-Palomo, C, Gonzalez-Santamaría, P , Yuste, L , Wörmann, SM, Kabacaoğlu, D, Earl, J, Martin, A , Salvador, F , Valle, S , Martin-Hijano, L , Carrato, A, Erkan, M, García-Bermejo, L, Hermann, PC, Algül, H, Moreno-Bueno, G , Heeschen, C, Portillo, F , Cano, A , Sainz, B . Gut (PMID: 35428659) (doi:10.1136/gutjnl-2021-325564)
25 feb | 2022 Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival. Vázquez-Naharro, A , Bustos-Tauler, J , Floristán, A , Yuste, L , Oltra, SS , Vinyals, A, Moreno-Bueno, G , Fabra, À, Portillo, F , Cano, A , Santamaría, PG . Cancers (Basel) - 14 (5) (PMID: 35267510) (doi:10.3390/cancers14051200)
24 feb | 2022 Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the in vivo Biological Context. Sarrio, D , Rojo-Sebastián, A, Teijo, A, Pérez-López, M , Díaz-Martín, E, Martínez, L , Morales, S , García-Sanz, P , Palacios, J, Moreno-Bueno, G . Front Cell Dev Biol - 10 : 813929 (PMID: 35281099) (doi:10.3389/fcell.2022.813929)
10 feb | 2022 Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression. Mota, A , Oltra, SS , Selenica, P, Moiola, CP, Casas-Arozamena, C, López-Gil, C, Diaz, E, Gatius, S, Ruiz-Miro, M, Calvo, A, Rojo-Sebastián, A, Hurtado, P, Piñeiro, R, Colas, E, Gil-Moreno, A, Reis-Filho, JS, Muinelo-Romay, L, Abal, M, Matias-Guiu, X, Weigelt, B, Moreno-Bueno, G . Oncogene (PMID: 35145232) (doi:10.1038/s41388-022-02221-0)
1 dic | 2021 The multifaceted roles of gasdermins in cancer biology and oncologic therapies. Sarrió, D , Martínez-Val, J, Molina-Crespo, Á , Sánchez, L, Moreno-Bueno, G . Biochim Biophys Acta Rev Cancer - 1876 (2) : 188635 (PMID: 34656686) (doi:10.1016/j.bbcan.2021.188635)
15 nov | 2021 The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer. García-Estevez, L, González-Martínez, S, Moreno-Bueno, G . Front Immunol - 12 : 784823 (PMID: 34868066) (doi:10.3389/fimmu.2021.784823)
13 ago | 2021 Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status. García-Estévez, L, Cortés, J, Pérez, S, Calvo, I, Gallegos, I, Moreno-Bueno, G . Front Oncol - 11 : 705911 (PMID: 34485137) (doi:10.3389/fonc.2021.705911)
29 jun | 2021 Predictive Role of Leptin Receptor (Ob-R) Overexpression in Patients with Early Breast Cancer Receiving Neoadjuvant Systemic Treatment. García-Estévez, L, Calvo, I, Pérez, S, Gallegos, I, Díaz, E, Sampayo-Cordero, M, Oltra, SS , Moreno-Bueno, G . Cancers (Basel) - 13 (13) (PMID: 34210055) (doi:10.3390/cancers13133269)
18 jun | 2021 E2A modulates stemness, metastasis, and therapeutic resistance of breast cancer. López-Menéndez, C , Vázquez-Naharro, A , Santos, V , Dubus, P, Santamaría, PG , Martínez-Ramírez, Á, Portillo, F , Moreno-Bueno, G , Faraldo, MM, Cano, A . Cancer Res (PMID: 34145034) (doi:10.1158/0008-5472.CAN-20-2685)
12 sep | 2020 Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma. Grilli, G, Hermida-Prado, F, Álvarez-Fernández, M, Allonca, E, Álvarez-González, M, Astudillo, A, Moreno-Bueno, G , Cano, A , García-Pedrero, JM, Rodrigo, JP. Oral Oncol. - 110 : 105003 (PMID: 32932170) (doi:10.1016/j.oraloncology.2020.105003)
22 ago | 2020 Insight updating of the molecular hallmarks in ovarian carcinoma. Mota, A , S Oltra, S , Moreno-Bueno, G . EJC Suppl - 15 : 16-26 (PMID: 33240439) (doi:10.1016/j.ejcsup.2019.11.001)
14 mayo | 2020 Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer. Abreu, M, Cabezas-Sainz, P, Alonso-Alconada, L, Ferreirós, A, Mondelo-Macía, P, Lago-Lestón, RM, Abalo, A, Díaz, E, Palacios-Zambrano, S , Rojo-Sebastian, A, López-López, R, Sánchez, L, Moreno-Bueno, G , Muinelo-Romay, L. Cells - 9 (5) (PMID: 32423054) (doi:10.3390/cells9051218)
15 abr | 2020 Corrigendum to "Prostaglandin F2α-induced prostate transmembrane protein, androgen induced 1 mediates ovarian cancer progression increasing epithelial plasticity" [Neoplasia 21 (2019) 1073-1084]. Jiménez-Segovia, A, Mota, A , Rojo-Sebastián, A, Barrocal, B, Rynne-Vidal, A, García-Bermejo, ML, Gómez-Bris, R, Hawinkels, LJAC, Sandoval, P, Garcia-Escudero, R, López-Cabrera, M, Moreno-Bueno, G , Fresno, M, Stamatakis, K. Neoplasia - 22 (5) : 217-219 (PMID: 32304913) (doi:10.1016/j.neo.2020.03.003)
21 feb | 2020 Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer. Casas-Arozamena, C, Díaz, E, Moiola, CP, Alonso-Alconada, L, Ferreirós, A, Abalo, A, Gil, CL, Oltra, SS , de Santiago, J, Cabrera, S, Sampayo, V, Bouso, M, Arias, E, Cueva, J, Colas, E, Vilar, A, Gil-Moreno, A, Abal, M, Moreno-Bueno, G , Muinelo-Romay, L. J Clin Med - 9 (2) (PMID: 32098121) (doi:10.3390/jcm9020585)
27 ene | 2020 Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells. Abreu, M, Cabezas-Sainz, P, Pereira-Veiga, T, Falo, C, Abalo, A, Morilla, I, Curiel, T, Cueva, J, Rodríguez, C, Varela-Pose, V, Lago-Lestón, R, Mondelo, P, Palacios, P, Moreno-Bueno, G , Cano, A , García-Caballero, T, Pujana, MÁ, Sánchez-Piñón, L, Costa, C, López, R, Muinelo-Romay, L. J Clin Med - 9 (2) (PMID: 32012729) (doi:10.3390/jcm9020353)
12 dic | 2019 Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer. Herrero, C, de la Fuente, A, Casas-Arozamena, C, Sebastian, V, Prieto, M, Arruebo, M, Abalo, A, Colás, E, Moreno-Bueno, G , Gil-Moreno, A, Vilar, A, Cueva, J, Abal, M, Muinelo-Romay, L. Cancers (Basel) - 11 (12) (PMID: 31842290) (doi:10.3390/cancers11122000)
14 nov | 2019 Prostaglandin F2α-induced Prostate Transmembrane Protein, Androgen Induced 1 mediates ovarian cancer progression increasing epithelial plasticity. Jiménez-Segovia, A, Mota, A , Rojo-Sebastián, A, Barrocal, B, Rynne-Vidal, A, García-Bermejo, ML, Gómez-Bris, R, Hawinkels, LJAC, Sandoval, P, Garcia-Escudero, R, López-Cabrera, M, Moreno-Bueno, G , Fresno, M, Stamatakis, K. Neoplasia - 21 (11) : 1073-1084 (PMID: 31734628) (doi:10.1016/j.neo.2019.10.001)
1 ago | 2019 MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways. Majem, B, Parrilla, A, Jiménez, C, Suárez-Cabrera, L, Barber, M, Marín, A, Castellví, J, Tamayo, G, Moreno-Bueno, G , Ponce, J, Matias-Guiu, X, Alameda, F, Romero, I, Sánchez, JL, Pérez-Benavente, A, Moran, S, Esteller, M, Reventós, J, Rigau, M, Gil-Moreno, A, Segura, MF, Santamaría, A. Oncogene - 38 (32) : 6035-6050 (PMID: 31278368) (doi:10.1038/s41388-019-0860-0)
18 jul | 2019 Exosome-mimetic nanoplatforms for targeted cancer drug delivery. Vázquez-Ríos, AJ, Molina-Crespo, Á , Bouzo, BL, López-López, R, Moreno-Bueno, G , de la Fuente, M. J Nanobiotechnology - 17 (1) : 85 (PMID: 31319859) (doi:10.1186/s12951-019-0517-8)
14 mayo | 2019 Contribution of Epithelial Plasticity to Therapy Resistance. Santamaría, PG , Moreno-Bueno, G , Cano, A . J Clin Med - 8 (5) (PMID: 31091749) (doi:10.3390/jcm8050676)
7 mayo | 2019 Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness. Molina-Crespo, Á , Cadete, A, Sarrio, D , Gámez-Chiachio, M , Martinez, L , Chao, K, Olivera, A, Gonella, A, Díaz, E, Palacios, J, Dhal, PK, Besev, M, Rodríguez-Serrano, M, García Bermejo, ML, Triviño, JC, Cano, A , García-Fuentes, M, Herzberg, O, Torres, D, Alonso, MJ, Moreno-Bueno, G . Clin. Cancer Res. (PMID: 31064780) (doi:10.1158/1078-0432.CCR-18-2381)
1 mar | 2019 Updating the role of obesity and cholesterol in breast cancer. Garcia-Estevez, L, Moreno-Bueno, G . Breast Cancer Res. - 21 (1) : 35 (PMID: 30823902) (doi:10.1186/s13058-019-1124-1)
26 feb | 2019 Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer. Blasco-Benito, S, Moreno, E, Seijo-Vila, M, Tundidor, I, Andradas, C, Caffarel, MM, Caro-Villalobos, M, Urigüen, L, Diez-Alarcia, R, Moreno-Bueno, G , Hernández, L, Manso, L, Homar-Ruano, P, McCormick, PJ, Bibic, L, Bernadó-Morales, C, Arribas, J, Canals, M, Casadó, V, Canela, EI, Guzmán, M, Pérez-Gómez, E , Sánchez, C. Proc. Natl. Acad. Sci. U.S.A. - 116 (9) : 3863-3872 (PMID: 30733293) (doi:10.1073/pnas.1815034116)
1 ene | 2019 A role for the Tgf-β/Bmp co-receptor Endoglin in the molecular oscillator that regulates the hair follicle cycle. Calvo-Sánchez, MI , Fernández-Martos, S, Carrasco, E , Moreno-Bueno, G , Bernabéu, C, Quintanilla, M , Espada, J . J Mol Cell Biol - 11 (1) : 39-52 (PMID: 30239775) (doi:10.1093/jmcb/mjy051)
29 ago | 2018 The Ras-related gene ERAS is involved in human and murine breast cancer. Suárez-Cabrera, C, de la Peña, B, González, LL, Page, A, Martínez-Fernández, M, Casanova, ML, Paramio, JM, Rojo-Sebastián, A, Moreno-Bueno, G , Maroto, A, Ramírez, Á, Navarro, M. Sci Rep - 8 (1) : 13038 (PMID: 30158566) (doi:10.1038/s41598-018-31326-4)
8 mar | 2018 In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines. Rincón-Fernández, D, Culler, MD, Tsomaia, N, Moreno-Bueno, G , Luque, RM, Gahete, MD, Castaño, JP. Carcinogenesis - 39 (3) : 447-457 (PMID: 29272342) (doi:10.1093/carcin/bgx146)
1 feb | 2018 A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination. Figueras, A, Alsina-Sanchís, E, Lahiguera, Á, Abreu, M, Muinelo-Romay, L, Moreno-Bueno, G , Casanovas, O, Graupera, M, Matias-Guiu, X, Vidal, A, Villanueva, A, Viñals, F. Mol. Cancer Ther. - 17 (2) : 532-543 (PMID: 29146630) (doi:10.1158/1535-7163.MCT-17-0643)
3 oct | 2017 Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells. Rodríguez-Ubreva, J, Català-Moll, F, Obermajer, N, Álvarez-Errico, D, Ramirez, RN, Company, C, Vento-Tormo, R, Moreno-Bueno, G , Edwards, RP, Mortazavi, A, Kalinski, P, Ballestar, E. Cell Rep - 21 (1) : 154-167 (PMID: 28978469) (doi:10.1016/j.celrep.2017.09.018)
18 jul | 2017 Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer. Salvador, F , Martin, A , López-Menéndez, C , Moreno-Bueno, G , Santos, V , Vazquez-Naharro, A, Santamaría, PG , Morales, S , Dubus, P, Muinelo-Romay, L, López López, R, Tung, JC, Weaver, VM, Portillo, F , Cano, A . Cancer Res. (PMID: 28720577) (doi:10.1158/0008-5472.CAN-16-3152)
7 jun | 2017 EMT: Present and future in clinical oncology. Santamaria, PG, Moreno-Bueno, G , Portillo, F , Cano, A . Mol Oncol (PMID: 28590039) (doi:10.1002/1878-0261.12091)
11 mayo | 2017 Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition. Mateo, F, Arenas, EJ, Aguilar, H, Serra-Musach, J, de Garibay, GR, Boni, J, Maicas, M, Du, S, Iorio, F, Herranz-Ors, C, Islam, A, Prado, X, Llorente, A, Petit, A, Vidal, A, Català, I, Soler, T, Venturas, G, Rojo-Sebastian, A, Serra, H, Cuadras, D, Blanco, I, Lozano, J, Canals, F, Sieuwerts, AM, de Weerd, V, Look, MP, Puertas, S, García, N, Perkins, AS, Bonifaci, N, Skowron, M, Gómez-Baldó, L, Hernández, V, Martínez-Aranda, A, Martínez-Iniesta, M, Serrat, X, Cerón, J, Brunet, J, Barretina, MP, Gil, M, Falo, C, Fernández, A, Morilla, I, Pernas, S, Plà, MJ, Andreu, X, Seguí, MA, Ballester, R, Castellà, E, Nellist, M, Morales, S, Valls, J, Velasco, A, Matias-Guiu, X, Figueras, A, Sánchez-Mut, JV, Sánchez-Céspedes, M, Cordero, A, Gómez-Miragaya, J, Palomero, L, Gómez, A, Gajewski, TF, Cohen, EEW, Jesiotr, M, Bodnar, L, Quintela-Fandino, M, López-Bigas, N, Valdés-Mas, R, Puente, XS, Viñals, F, Casanovas, O, Graupera, M, Hernández-Losa, J, Ramón Y Cajal, S, García-Alonso, L, Saez-Rodriguez, J, Esteller, M, Sierra, A, Martín-Martín, N, Matheu, A, Carracedo, A, González-Suárez, E, Nanjundan, M, Cortés, J, Lázaro, C, Odero, MD, Martens, JWM, Moreno-Bueno, G , Barcellos-Hoff, MH, Villanueva, A, Gomis, RR, Pujana, MA. Oncogene - 36 (19) : 2737-2749 (PMID: 27991928) (doi:10.1038/onc.2016.427)
1 abr | 2017 Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma. García-Sanz, P , Triviño, JC, Mota, A , Pérez López, M, Colás, E, Rojo-Sebastián, A, García, Á, Gatius, S, Ruiz, M, Prat, J, López-López, R, Abal, M, Gil-Moreno, A, Reventós, J, Matias-Guiu, X, Moreno-Bueno, G . Int. J. Cancer - 140 (7) : 1551-1563 (PMID: 27997699) (doi:10.1002/ijc.30573)
23 mar | 2017 LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway. Cuevas, EP , Eraso, P , Mazón, MJ , Santos, V , Moreno-Bueno, G , Cano, A , Portillo, F . Sci Rep - 7 : 44988 (PMID: 28332555) (doi:10.1038/srep44988)
1 mar | 2017 Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer. Devis, L, Moiola, CP, Masia, N, Martinez-Garcia, E, Santacana, M, Stirbat, TV, Brochard-Wyart, F, García, Á, Alameda, F, Cabrera, S, Palacios, J, Moreno-Bueno, G , Abal, M, Thomas, W, Dufour, S, Matias-Guiu, X, Santamaria, A, Reventos, J, Gil-Moreno, A, Colas, E. J. Pathol. - 241 (4) : 475-487 (PMID: 27873306) (doi:10.1002/path.4851)
1 ene | 2017 Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers. Mota, A , Colás, E, García-Sanz, P , Campoy, I, Rojo-Sebastián, A, Gatius, S, García, Á, Chiva, L, Alonso, S, Gil-Moreno, A, González-Tallada, X, Díaz-Feijoo, B, Vidal, A, Ziober-Malinowska, P, Bobiński, M, López-López, R, Abal, M, Reventós, J, Matias-Guiu, X, Moreno-Bueno, G . Mod. Pathol. - 30 (1) : 134-145 (PMID: 27586201) (doi:10.1038/modpathol.2016.143)
13 sep | 2016 The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients. Gahete, MD, Rincón-Fernández, D, Durán-Prado, M, Hergueta-Redondo, M , Ibáñez-Costa, A, Rojo-Sebastián, A, Gracia-Navarro, F, Culler, MD, Casanovas, O, Moreno-Bueno, G , Luque, RM, Castaño, JP. Oncotarget - 7 (37) : 60110-60122 (PMID: 27507050) (doi:10.18632/oncotarget.11076)
24 ago | 2016 Cancer network activity associated with therapeutic response and synergism. Serra-Musach, J, Mateo, F, Capdevila-Busquets, E, de Garibay, GR, Zhang, X, Guha, R, Thomas, CJ, Grueso, J, Villanueva, A, Jaeger, S, Heyn, H, Vizoso, M, Pérez, H, Cordero, A, Gonzalez-Suarez, E, Esteller, M, Moreno-Bueno, G , Tjärnberg, A, Lázaro, C, Serra, V, Arribas, J, Benson, M, Gustafsson, M, Ferrer, M, Aloy, P, Pujana, MÀ. Genome Med - 8 (1) : 88 (PMID: 27553366) (doi:10.1186/s13073-016-0340-x)
1 ago | 2016 Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies. Hellner, K, Miranda, F, Fotso Chedom, D, Herrero-Gonzalez, S, Hayden, DM, Tearle, R, Artibani, M, KaramiNejadRanjbar, M, Williams, R, Gaitskell, K, Elorbany, S, Xu, R, Laios, A, Buiga, P, Ahmed, K, Dhar, S, Zhang, RY, Campo, L, Myers, KA, Lozano, M, Ruiz-Miró, M, Gatius, S, Mota, A , Moreno-Bueno, G , Matias-Guiu, X, Benítez, J, Witty, L, McVean, G, Leedham, S, Tomlinson, I, Drmanac, R, Cazier, JB, Klein, R, Dunne, K, Bast, RC, Kennedy, SH, Hassan, B, Lise, S, Garcia, MJ, Peters, BA, Yau, C, Sauka-Spengler, T, Ahmed, AA. EBioMedicine - 10 : 137-149 (PMID: 27492892) (doi:10.1016/j.ebiom.2016.06.048)
22 jul | 2016 Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer. Hergueta-Redondo, M , Sarrio, D , Molina-Crespo, Á , Vicario, R, Bernadó-Morales, C, Martínez, L , Rojo-Sebastián, A, Serra-Musach, J, Mota, A , Martínez-Ramírez, Á, Castilla, MÁ, González-Martin, A, Pernas, S, Cano, A , Cortes, J, Nuciforo, PG, Peg, V, Palacios, J, Pujana, MÁ, Arribas, J, Moreno-Bueno, G . Oncotarget (PMID: 27462779) (doi:10.18632/oncotarget.10787)
7 jul | 2016 The homeoprotein SIX1 controls cellular senescence through the regulation of p16INK4A and differentiation-related genes. Adrados, I, Larrasa-Alonso, J, Galarreta, A, López-Antona, I, Menéndez, C, Abad, M, Gil, J, Moreno-Bueno, G , Palmero, I . Oncogene - 35 (27) : 3485-3494 (PMID: 26500063) (doi:10.1038/onc.2015.408)
2 jun | 2016 Biological Effects of Temsirolimus on the mTOR Pathway in Endometrial Carcinoma: A Pharmacodynamic Phase II Study. Santacana, M, Coronado, P, Matias-Guiu, X, Romero, I, Casado, A, Gil-Moreno, A, Dosil, MA, Mota, A , Moreno-Bueno, G , Dolcet, X, Llombart-Cussac, A, Poveda, A. Int. J. Gynecol. Cancer (PMID: 27258723) (doi:10.1097/IGC.0000000000000715)
1 feb | 2016 Study of breast cancer incidence in patients of lymphangioleiomyomatosis. Nuñez, O, Román, A, Johnson, SR, Inoue, Y, Hirose, M, Casanova, Á, de Garibay, GR, Herranz, C, Bueno-Moreno, G , Boni, J, Mateo, F, Petit, A, Climent, F, Soler, T, Vidal, A, Sánchez-Mut, JV, Esteller, M, López, JI, García, N, Gumà, A, Ortega, R, Plà, MJ, Campos, M, Ansótegui, E, Molina-Molina, M, Valenzuela, C, Ussetti, P, Laporta, R, Ancochea, J, Xaubet, A, Pollán, M, Pujana, MA. Breast Cancer Res. Treat. - 156 (1) : 195-201 (PMID: 26951504) (doi:10.1007/s10549-016-3737-8)
30 nov | 2015 Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression. Mota, A , Triviño, JC, Rojo-Sebastian, A, Martínez-Ramírez, Á, Chiva, L, González-Martín, A, Garcia, JF, Garcia-Sanz, P , Moreno-Bueno, G . BMC Cancer - 15 (1) : 940 (PMID: 26620706) (doi:10.1186/s12885-015-1952-z)
10 nov | 2015 Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells. Castellana, B, Aasen, T, Moreno-Bueno, G , Dunn, SE, Ramón y Cajal, S. Oncotarget - 6 (35) : 38239-38256 (PMID: 26512918) (doi:10.18632/oncotarget.5664)
1 nov | 2015 A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer. Romero-Pérez, L, Garcia-Sanz, P , Mota, A , Leskelä, S, Hergueta-Redondo, M , Díaz-Martín, J, López-García, MA, Castilla, MA, Martínez-Ramírez, A, Soslow, RA, Matias-Guiu, X, Moreno-Bueno, G , Palacios, J. Mod. Pathol. - 28 (11) : 1492-1503 (PMID: 26381823) (doi:10.1038/modpathol.2015.102)
29 jun | 2015 Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer. Pérez-Gómez, E , Andradas, C, Blasco-Benito, S, Caffarel, MM, García-Taboada, E, Villa-Morales, M, Moreno, E, Hamann, S, Martín-Villar, E , Flores, JM, Wenners, A, Alkatout, I, Klapper, W, Röcken, C, Bronsert, P, Stickeler, E, Staebler, A, Bauer, M, Arnold, N, Soriano, J, Pérez-Martínez, M, Megías, D, Moreno-Bueno, G , Ortega-Gutiérrez, S, Artola, M, Vázquez-Villa, H, Quintanilla, M , Fernández-Piqueras, J, Canela, EI, McCormick, PJ, Guzmán, M, Sánchez, C. J. Natl. Cancer Inst. - 107 (6) : djv077 (PMID: 25855725) (doi:10.1093/jnci/djv077)
14 mayo | 2015 EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination. Gómez-Maldonado, L, Tiana, M, Roche, O, Prado-Cabrero, A, Jensen, L, Fernandez-Barral, A, Guijarro-Muñoz, I, Favaro, E, Moreno-Bueno, G , Sanz, L, Aragones, J, Harris, A, Volpert, O, Jimenez, B , del Peso, L . Oncogene - 34 (20) : 2609-2620 (PMID: 25023702) (doi:10.1038/onc.2014.200)
1 mayo | 2015 Loss of Snail2 favors skin tumor progression by promoting the recruitment of myeloid progenitors. Villarejo, A , Molina-Ortiz, P , Montenegro, Y , Moreno-Bueno, G , Morales, S , Santos, V , Gridley, T, Pérez-Moreno, MA, Peinado, H , Portillo, F , Calés, C , Cano, A . Carcinogenesis - 36 (5) : 585-597 (PMID: 25784375) (doi:10.1093/carcin/bgv021)
15 abr | 2015 Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. Martin, A , Salvador, F , Moreno-Bueno, G , Floristán, A , Ruiz-Herguido, C, Cuevas, EP , Morales, S , Santos, V , Csiszar, K, Dubus, P, Haigh, JJ, Bigas, A, Portillo, F , Cano, A . EMBO J. - 34 (8) : 1090-1109 (PMID: 25759215) (doi:10.15252/embj.201489975)
19 feb | 2015 Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization. Canesin, G, Cuevas, EP, Santos, V, López-Menéndez, C , Moreno-Bueno, G , Huang, Y, Csiszar, K, Portillo, F , Peinado, H , Lyden, D, Cano, A . Oncogene - 34 (8) : 951-964 (PMID: 24632622) (doi:10.1038/onc.2014.23)
15 feb | 2015 Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT. Díaz-López, A, Díaz-Martín, J, Moreno-Bueno, G , Cuevas, EP , Santos, V , Olmeda, D , Portillo, F , Palacios, J, Cano, A . Int. J. Cancer - 136 (4) : E62-73 (PMID: 25178837) (doi:10.1002/ijc.29177)
3 dic | 2014 A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry. Santacana, M, Maiques, O, Valls, J, Gatius, S, Abó, AI, López-García, MÁ, Mota, A , Reventós, J, Moreno-Bueno, G , Palacios, J, Bartosch, C, Dolcet, X, Matias-Guiu, X. Hum. Pathol. - 45 (12) : 2394-2403 (PMID: 25282036) (doi:10.1016/j.humpath.2014.06.031)
8 ago | 2014 Sin3b interacts with Myc and decreases Myc levels. Garcia-Sanz, P , Quintanilla, A, Lafita, MC, Moreno-Bueno, G , García-Gutierrez, L, Tabor, V, Varela, I, Shiio, Y, Larsson, LG, Portillo, F , Leon, J. J. Biol. Chem. - 289 (32) : 22221-22236 (PMID: 24951594) (doi:10.1074/jbc.M113.538744)
5 jun | 2014 MicroRNAs as prognostic markers in ovarian cancer. Llauradó, M, Majem, B, Altadill, T, Lanau, L, Castellví, J, Sánchez-Iglesias, JL, Cabrera, S, De la Torre, J, Díaz-Feijoo, B, Pérez-Benavente, A, Colás, E, Olivan, M, Doll, A, Alameda, F, Matias-Guiu, X, Moreno-Bueno, G , Carey, MS, Del Campo, JM, Gil-Moreno, A, Reventós, J, Rigau, M. Mol. Cell. Endocrinol. - 390 (1-2) : 73-84 (PMID: 24747602) (doi:10.1016/j.mce.2014.03.006)
25 abr | 2014 Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Díaz-López, A, Moreno-Bueno, G , Cano, A . Cancer Manag Res - 6 : 205-216 (PMID: 24812525) (doi:10.2147/CMAR.S38156)
10 abr | 2014 ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth. Moreno, A, Soleto, I, García-Sanz, P, Moreno-Bueno, G , Palmero, I . Oncogene - 33 (15) : 1945-1953 (PMID: 23604125) (doi:10.1038/onc.2013.145)
27 mar | 2014 Gasdermin-B promotes invasion and metastasis in breast cancer cells. Hergueta-Redondo, M , Sarrió, D , Molina-Crespo, Á , Megias, D, Mota, A , Rojo-Sebastian, A, García-Sanz, P , Morales, S , Abril, S, Cano, A , Peinado, H , Moreno-Bueno, G . PLoS ONE - 9 (3) : e90099 (PMID: 24675552) (doi:10.1371/journal.pone.0090099)
13 mar | 2014 MicroRNA-dependent regulation of transcription in non-small cell lung cancer. Molina-Pinelo, S, Gutiérrez, G, Pastor, MD, Hergueta, M, Moreno-Bueno, G , García-Carbonero, R, Nogal, A, Suárez, R, Salinas, A, Pozo-Rodríguez, F, Lopez-Rios, F, Agulló-Ortuño, MT, Ferrer, I, Perpiñá, A, Palacios, J, Carnero, A, Paz-Ares, L. PLoS ONE - 9 (3) : e90524 (PMID: 24625834) (doi:10.1371/journal.pone.0090524)
15 feb | 2014 LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition. Cuevas, EP , Moreno-Bueno, G , Canesin, G, Santos, V , Portillo, F , Cano, A . Biol Open - 3 (2) : 129-137 (PMID: 24414204) (doi:10.1242/bio.20146841)
26 mar | 2013 E47 and Id1 interplay in epithelial-mesenchymal transition. Cubillo, E , Diaz-Lopez, A, Cuevas, EP , Moreno-Bueno, G , Peinado, H , Montes, A , Santos, V , Portillo, F , Cano, A . PLoS ONE - 8 (3) : e59948 (PMID: 23555842) (doi:10.1371/journal.pone.0059948)
1 feb | 2013 Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis. Romero-Pérez, L, Castilla, MÁ, López-García, MÁ, Díaz-Martín, J, Biscuola, M, Ramiro-Fuentes, S, Oliva, E, Matias-Guiu, X, Prat, J, Cano, A , Moreno-Bueno, G , Palacios, J. Hum. Pathol. - 44 (2) : 244-254 (PMID: 22974476) (doi:10.1016/j.humpath.2012.05.013)
11 dic | 2012 Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Ocaña, OH, Córcoles, R, Fabra, A, Moreno-Bueno, G , Acloque, H, Vega, S , Barrallo-Gimeno, A, Cano, A , Nieto, MA. Cancer Cell - 22 (6) : 709-724 (PMID: 23201163) (doi:10.1016/j.ccr.2012.10.012)
1 sep | 2012 LOXL2 in epithelial cell plasticity and tumor progression. Cano, A , Santamaría, PG , Moreno-Bueno, G . Future Oncol - 8 (9) : 1095-1108 (PMID: 23030485) (doi:10.2217/fon.12.105)
1 jun | 2012 Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Peinado, H , Alečković, M, Lavotshkin, S, Matei, I, Costa-Silva, B, Moreno-Bueno, G , Hergueta-Redondo, M , Williams, C, García-Santos, G, Ghajar, C, Nitadori-Hoshino, A, Hoffman, C, Badal, K, Garcia, BA, Callahan, MK, Yuan, J, Martins, VR, Skog, J, Kaplan, RN, Brady, MS, Wolchok, JD, Chapman, PB, Kang, Y, Bromberg, J, Lyden, D. Nat. Med. - 18 (6) : 883-891 (PMID: 22635005) (doi:10.1038/nm.2753)
19 abr | 2012 The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells. Durán-Prado, M, Gahete, MD, Hergueta-Redondo, M, Martínez-Fuentes, AJ, Córdoba-Chacón, J, Palacios, J, Gracia-Navarro, F, Moreno-Bueno, G , Malagón, MM, Luque, RM, Castaño, JP. Oncogene - 31 (16) : 2049-2061 (PMID: 21927030) (doi:10.1038/onc.2011.389)
2 sep | 2011 Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. Moreno-Bueno, G , Salvador, F , Martín, A , Floristán, A , Cuevas, EP , Santos, V , Montes, A , Morales, S , Castilla, MA, Rojo-Sebastián, A, Martínez, A, Hardisson, D, Csiszar, K, Portillo, F , Peinado, H , Palacios, J, Cano, A . EMBO Mol Med - 3 (9) : 528-544 (PMID: 21732535) (doi:10.1002/emmm.201100156)
4 ago | 2011 A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance. Gahete, MD, Córdoba-Chacón, J, Hergueta-Redondo, M , Martínez-Fuentes, AJ, Kineman, RD, Moreno-Bueno, G , Luque, RM, Castaño, JP. PLoS ONE - 6 (8) : e23302 (PMID: 21829727) (doi:10.1371/journal.pone.0023302)
1 abr | 2011 KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. Llobet, D, Eritja, N, Domingo, M, Bergada, L, Mirantes, C, Santacana, M, Pallares, J, Macià, A, Yeramian, A, Encinas, M, Moreno-Bueno, G , Palacios, J, Lewis, RE, Matias-Guiu, X, Dolcet, X. Am. J. Pathol. - 178 (4) : 1529-1543 (PMID: 21435442) (doi:10.1016/j.ajpath.2010.12.041)
1 feb | 2011 The tumor suppressor ING1 contributes to epigenetic control of cellular senescence. Abad, M , Moreno, A , Palacios, A, Narita, M, Blanco, F, Moreno-Bueno, G , Narita, M, Palmero, I . Aging Cell - 10 (1) : 158-171 (PMID: 21078114) (doi:10.1111/j.1474-9726.2010.00651.x)
1 ene | 2011 Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. Castilla, MÁ, Moreno-Bueno, G , Romero-Pérez, L, Van De Vijver, K, Biscuola, M, López-García, MÁ, Prat, J, Matías-Guiu, X, Cano, A , Oliva, E, Palacios, J. J. Pathol. - 223 (1) : 72-80 (PMID: 21125666) (doi:10.1002/path.2802)
1 oct | 2010 Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. Castilla, MA, Moreno-Bueno, G , Romero-Pérez, L, De Vijver, KV, Biscuola, M, López-García, MA, Prat, J, Matías-Guiu, X, Cano, A , Oliva, E, Palacios, J. J. Pathol. (PMID: 21038317)
22 jul | 2010 Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Caffarel, MM, Andradas, C, Mira, E, Pérez-Gómez, E , Cerutti, C, Moreno-Bueno, G , Flores, JM, García-Real, I, Palacios, J, Mañes, S, Guzmán, M, Sánchez, C. Mol. Cancer - 9 : 196 (PMID: 20649976) (doi:10.1186/1476-4598-9-196)
15 oct | 2009 The morphological and molecular features of the epithelial-to-mesenchymal transition. Moreno-Bueno, G , Peinado, H , Molina, P , Olmeda, D , Cubillo, E , Santos, V , Palacios, J, Portillo, F , Cano, A . Nat Protoc - 4 (11) : 1591-1613 (PMID: 19834475) (doi:10.1038/nprot.2009.152)
18 ago | 2009 Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases. Geyer, JT, López-García, MA, Sánchez-Estevez, C, Sarrió, D , Moreno-Bueno, G , Franceschetti, I, Palacios, J, Oliva, E. Am. J. Surg. Pathol. - 33 (8) : 1157-1163 (PMID: 19542870) (doi:10.1097/PAS.0b013e3181a902e1)
4 ago | 2009 Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma. Fernandez-Marcos, PJ, Abu-Baker, S, Joshi, J, Galvez, A, Castilla, EA, Cañamero, M, Collado, M, Saez, C, Moreno-Bueno, G , Palacios, J, Leitges, M, Serrano, M, Moscat, J, Diaz-Meco, MT. Proc. Natl. Acad. Sci. U.S.A. - 106 (31) : 12962-12967 (PMID: 19470463) (doi:10.1073/pnas.0813055106)
15 abr | 2009 Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Natrajan, R, Lambros, MB, Rodríguez-Pinilla, SM, Moreno-Bueno, G , Tan, DS, Marchió, C, Vatcheva, R, Rayter, S, Mahler-Araujo, B, Fulford, LG, Hungermann, D, Mackay, A, Grigoriadis, A, Fenwick, K, Tamber, N, Hardisson, D, Tutt, A, Palacios, J, Lord, CJ, Buerger, H, Ashworth, A, Reis-Filho, JS. Clin. Cancer Res. - 15 (8) : 2711-2722 (PMID: 19318498) (doi:10.1158/1078-0432.CCR-08-1878)
1 abr | 2009 The class I bHLH factors E2-2A and E2-2B regulate EMT. Sobrado, VR , Moreno-Bueno, G , Cubillo, E , Holt, LJ, Nieto, MA, Portillo, F , Cano, A . J. Cell. Sci. - 122 (Pt 7) : 1014-1024 (PMID: 19295128) (doi:10.1242/jcs.028241)
3 mar | 2009 Functional characterization of E- and P-cadherin in invasive breast cancer cells. Sarrió, D , Palacios, J, Hergueta-Redondo, M , Gómez-López, G, Cano, A , Moreno-Bueno, G . BMC Cancer - 9 : 74 (PMID: 19257890) (doi:10.1186/1471-2407-9-74)
10 dic | 2008 "New" molecular taxonomy in breast cancer. Hergueta-Redondo, M , Palacios, J, Cano, A , Moreno-Bueno, G . Clin Transl Oncol - 10 (12) : 777-785 (PMID: 19068448)
3 dic | 2008 PAI-1 and functional blockade of SNAI1 in breast cancer cell migration. Fabre-Guillevin, E, Malo, M, Cartier-Michaud, A, Peinado, H , Moreno-Bueno, G , Vallée, B, Lawrence, DA, Palacios, J, Cano, A , Barlovatz-Meimon, G, Charrière-Bertrand, C. Breast Cancer Res. - 10 (6) : R100 (PMID: 19055748) (doi:10.1186/bcr2203)
24 nov | 2008 Transcriptional regulation of cell polarity in EMT and cancer. Moreno-Bueno, G , Portillo, F , Cano, A . Oncogene - 27 (55) : 6958-6969 (PMID: 19029937) (doi:10.1038/onc.2008.346)
1 sep | 2008 Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer. Durán, MC, Vega, F, Moreno-Bueno, G , Artiga, MJ, Sanchez, L, Palacios, J, Ridley, A, Timms, JF. Proteomics Clin Appl - 2 (9) : 1313-1326 (PMID: 21136925) (doi:10.1002/prca.200780020)
28 ago | 2008 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Caffarel, MM, Moreno-Bueno, G , Cerutti, C, Palacios, J, Guzman, M, Mechta-Grigoriou, F, Sanchez, C. Oncogene - 27 (37) : 5033-5044 (PMID: 18454173) (doi:10.1038/onc.2008.145)
7 ago | 2008 Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines. Olmeda, D , Montes, A, Moreno-Bueno, G , Flores, JM, Portillo, F , Cano, A . Oncogene - 27 (34) : 4690-4701 (PMID: 18408755) (doi:10.1038/onc.2008.118)
1 ago | 2008 Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen. Turbiner, J, Moreno-Bueno, G , Dahiya, S, Sánchez-Estevez, C, Hardisson, D, Prat, J, Oliva, E, Palacios, J. Mod. Pathol. - 21 (8) : 925-936 (PMID: 18500270) (doi:10.1038/modpathol.2008.49)
15 jun | 2008 Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Peinado, H , Moreno-Bueno, G , Hardisson, D, Pérez-Gómez, E , Santos, V , Mendiola, M , de Diego, JI , Nistal, M, Quintanilla, M , Portillo, F , Cano, A . Cancer Res. - 68 (12) : 4541-4550 (PMID: 18559498) (doi:10.1158/0008-5472.CAN-07-6345)
15 feb | 2008 Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Sarrió, D , Rodriguez-Pinilla, SM, Hardisson, D, Cano, A , Moreno-Bueno, G , Palacios, J. Cancer Res. - 68 (4) : 989-997 (PMID: 18281472) (doi:10.1158/0008-5472.CAN-07-2017)
15 dic | 2007 SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Olmeda, D , Moreno-Bueno, G , Flores, JM, Fabra, A, Portillo, F , Cano, A . Cancer Res. - 67 (24) : 11721-11731 (PMID: 18089802) (doi:10.1158/0008-5472.CAN-07-2318)
1 nov | 2007 Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner. Hernández-Vargas, H, von Kobbe, C, Sánchez-Estévez, C, Julián-Tendero, M , Palacios, J, Moreno-Bueno, G . Cell Cycle - 6 (21) : 2662-2668 (PMID: 17912036)
1 sep | 2007 Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. Rodríguez-Pinilla, SM, Sarrió, D , Honrado, E, Moreno-Bueno, G , Hardisson, D, Calero, F, Benítez, J, Palacios, J. J. Clin. Pathol. - 60 (9) : 1006-1012 (PMID: 17105822) (doi:10.1136/jcp.2006.042143)
3 mayo | 2007 Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis. Hernández-Vargas, H, Palacios, J, Moreno-Bueno, G . Oncogene - 26 (20) : 2902-2913 (PMID: 17099726) (doi:10.1038/sj.onc.1210102)
6 abr | 2007 Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study. Rodríguez-Pinilla, SM, Rodríguez-Gil, Y, Moreno-Bueno, G , Sarrió, D , Martín-Guijarro, Mdel C, Hernandez, L, Palacios, J. Am. J. Surg. Pathol. - 31 (4) : 501-508 (PMID: 17414096) (doi:10.1097/01.pas.0000213427.84245.92)
1 abr | 2007 Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Hernández-Vargas, H, Rodríguez-Pinilla, SM, Julián-Tendero, M , Sánchez-Rovira, P, Cuevas, C, Antón, A, Ríos, MJ, Palacios, J, Moreno-Bueno, G . Breast Cancer Res. Treat. - 102 (2) : 157-172 (PMID: 17039268) (doi:10.1007/s10549-006-9322-9)
1 abr | 2007 Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Rodriguez-Pinilla, SM, Sarrio, D , Moreno-Bueno, G , Rodriguez-Gil, Y, Martinez, MA, Hernandez, L, Hardisson, D, Reis-Filho, JS, Palacios, J. Mod. Pathol. - 20 (4) : 474-481 (PMID: 17334350) (doi:10.1038/modpathol.3800760)
1 abr | 2007 Telling cells how to die: docetaxel therapy in cancer cell lines. Hernández-Vargas, H, Palacios, J, Moreno-Bueno, G . Cell Cycle - 6 (7) : 780-783 (PMID: 17377494)
1 mar | 2007 Inactivation of the candidate tumor suppressor par-4 in endometrial cancer. Moreno-Bueno, G , Fernandez-Marcos, PJ, Collado, M, Tendero, MJ, Rodriguez-Pinilla, SM, Garcia-Cao, I, Hardisson, D, Diaz-Meco, MT, Moscat, J, Serrano, M, Palacios, J. Cancer Res. - 67 (5) : 1927-1934 (PMID: 17332319) (doi:10.1158/0008-5472.CAN-06-2687)
15 dic | 2006 Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells. Molina-Arcas, M, Moreno-Bueno, G , Cano-Soldado, P, Hernández-Vargas, H, Casado, FJ, Palacios, J, Pastor-Anglada, M. Biochem. Pharmacol. - 72 (12) : 1646-1656 (PMID: 16965766) (doi:10.1016/j.bcp.2006.07.036)
1 oct | 2006 Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Moreno-Bueno, G , Cubillo, E , Sarrió, D , Peinado, H , Rodríguez-Pinilla, SM, Villa, S , Bolós, V , Jordá, M, Fabra, A, Portillo, F , Palacios, J, Cano, A . Cancer Res. - 66 (19) : 9543-9556 (PMID: 17018611) (doi:10.1158/0008-5472.CAN-06-0479)
1 sep | 2006 Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Hernández-Vargas, H, Ballestar, E, Carmona-Saez, P, von Kobbe, C, Bañón-Rodríguez, I, Esteller, M, Moreno-Bueno, G , Palacios, J. Int. J. Cancer - 119 (5) : 1164-1175 (PMID: 16557594) (doi:10.1002/ijc.21938)
1 ago | 2006 Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas. Sarrió, D , Moreno-Bueno, G , Sánchez-Estévez, C, Bañón-Rodríguez, I, Hernández-Cortés, G, Hardisson, D, Palacios, J. Hum. Pathol. - 37 (8) : 1042-1049 (PMID: 16867867) (doi:10.1016/j.humpath.2006.03.003)
15 jun | 2006 Low frequency of BRAF mutations in endometrial and in cervical carcinomas. Moreno-Bueno, G , Sanchez-Estevez, C, Palacios, J, Hardisson, D, Shiozawa, T. Clin. Cancer Res. - 12 (12) : 3865; author reply 3865-6 (PMID: 16778116) (doi:10.1158/1078-0432.CCR-06-0284)
1 abr | 2006 High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary. Oliva, E, Sarrió, D, Brachtel, EF, Sánchez-Estévez, C, Soslow, RA, Moreno-Bueno, G , Palacios, J. J Pathol - 208 (5) : 708-713 (PMID: 16429393) (doi:10.1002/path.1923)
1 oct | 2005 Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules). Brachtel, EF, Sánchez-Estevez, C, Moreno-Bueno, G , Prat, J, Palacios, J, Oliva, E. Am J Surg Pathol - 29 (10) : 1322-1329 (PMID: 16160475) (doi:10.1097/01.pas.0000171001.87599.e2)
1 oct | 2004 Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting. Matar, P, Rojo, F, Cassia, R, Moreno-Bueno, G , Di Cosimo, S, Tabernero, J, Guzmán, M, Rodriguez, S, Arribas, J, Palacios, J, Baselga, J. Clin. Cancer Res. - 10 (19) : 6487-6501 (PMID: 15475436) (doi:10.1158/1078-0432.CCR-04-0870)
10 jun | 2004 Molecular alterations associated with cyclin D1 overexpression in endometrial cancer. Moreno-Bueno, G , Rodríguez-Perales, S, Sánchez-Estévez, C, Marcos, R, Hardisson, D, Cigudosa, JC, Palacios, J. Int. J. Cancer - 110 (2) : 194-200 (PMID: 15069681) (doi:10.1002/ijc.20130)
22 abr | 2004 Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Sarrió, D , Pérez-Mies, B, Hardisson, D, Moreno-Bueno, G , Suárez, A, Cano, A , Martín-Pérez, J , Gamallo, C , Palacios, J. Oncogene - 23 (19) : 3272-3283 (PMID: 15077190) (doi:10.1038/sj.onc.1207439)
19 abr | 2004 Re: Scholten et al. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460-465. Moreno-Bueno, G , Hardisson, D, Prat, J, Matías-Guiu, J, Palacios, J. J. Pathol. - 202 (4) : 511-512 (PMID: 15095279) (doi:10.1002/path.1540)
3 dic | 2003 Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. Cassia, R, Moreno-Bueno, G , Rodríguez-Perales, S, Hardisson, D, Cigudosa, JC, Palacios, J. J. Pathol. - 201 (4) : 589-595 (PMID: 14648662) (doi:10.1002/path.1474)
17 nov | 2003 Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability. Hardisson, D, Moreno-Bueno, G , Sánchez, L, Sarrió, D , Suárez, A, Calero, F, Palacios, J. Mod. Pathol. - 16 (11) : 1148-1158 (PMID: 14614055) (doi:10.1097/01.MP.0000095646.70007.6A)
15 sep | 2003 Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Moreno-Bueno, G , Sánchez-Estévez, C, Cassia, R, Rodríguez-Perales, S, Díaz-Uriarte, R , Domínguez, O, Hardisson, D, Andujar, M, Prat, J, Matias-Guiu, X, Cigudosa, JC, Palacios, J. Cancer Res. - 63 (18) : 5697-5702 (PMID: 14522886)
4 sep | 2003 Cyclin D1 gene (CCND1) mutations in endometrial cancer. Moreno-Bueno, G , Rodríguez-Perales, S, Sánchez-Estévez, C, Hardisson, D, Sarrió, D , Prat, J, Cigudosa, JC, Matias-Guiu, X, Palacios, J. Oncogene - 22 (38) : 6115-6118 (PMID: 12955092) (doi:10.1038/sj.onc.1206868)
20 ago | 2003 Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Sarrió, D , Moreno-Bueno, G , Hardisson, D, Sánchez-Estévez, C, Guo, M, Herman, JG, Gamallo, C , Esteller, M, Palacios, J. Int. J. Cancer - 106 (2) : 208-215 (PMID: 12800196) (doi:10.1002/ijc.11197)
1 abr | 2003 Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. Moreno-Bueno, G , Hardisson, D, Sarrió, D , Sánchez, C, Cassia, R, Prat, J, Herman, JG, Esteller, M, Matías-Guiu, X, Palacios, J. J. Pathol. - 199 (4) : 471-478 (PMID: 12635138) (doi:10.1002/path.1310)
14 nov | 2002 Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Moreno-Bueno, G , Hardisson, D, Sánchez, C, Sarrió, D , Cassia, R, García-Rostán, G, Prat, J, Guo, M, Herman, JG, Matías-Guiu, X, Esteller, M, Palacios, J. Oncogene - 21 (52) : 7981-7990 (PMID: 12439748) (doi:10.1038/sj.onc.1205924)
9 mayo | 2002 Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Blanco, MJ, Moreno-Bueno, G , Sarrio, D , Locascio, A, Cano, A , Palacios, J, Nieto, MA. Oncogene - 21 (20) : 3241-3246 (PMID: 12082640) (doi:10.1038/sj.onc.1205416)
1 dic | 2001 Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Gras, E, Catasus, L, Argüelles, R, Moreno-Bueno, G , Palacios, J, Gamallo, C , Matias-Guiu, X, Prat, J. Cancer - 92 (11) : 2829-2836 (PMID: 11753956)
1 oct | 2001 beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles. Moreno-Bueno, G , Gamallo, C , Pérez-Gallego, L, Contreras, F, Palacios, J. Br. J. Dermatol. - 145 (4) : 576-581 (PMID: 11703283)
1 oct | 2001 Correlation of p53 oncoprotein expression with chemotherapy response in small cell lung carcinomas. Rodríguez-Salas, N, Palacios, J, Moreno, G , de Castro, J, González-Barón, M, Gamallo, C . Lung Cancer - 34 (1) : 67-74 (PMID: 11557115)
26 jul | 2001 Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women. Pérez-Gallego, L, Moreno-Bueno, G , Sarrió, D, Suárez, A, Gamallo, C , Palacios, J. Am. J. Clin. Pathol. - 116 (1) : 143-148 (PMID: 11447745) (doi:10.1309/42U5-Q2EV-RCBM-WPGJ)
16 jul | 2001 The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Gamallo, C , Moreno-Bueno, G , Sarrió, D, Calero, F, Hardisson, D, Palacios, J. Mod. Pathol. - 14 (7) : 650-654 (PMID: 11454996) (doi:10.1038/modpathol.3880367)
1 jun | 2001 beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Moreno-Bueno, G , Gamallo, C , Pérez-Gallego, L, de Mora, JC, Suárez, A, Palacios, J. Diagn. Mol. Pathol. - 10 (2) : 116-122 (PMID: 11385321)
1 mayo | 2001 Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability. Palacios, J, Catasús, L, Moreno-Bueno, G , Matias-Guiu, X, Prat, J, Gamallo, C . Virchows Arch. - 438 (5) : 464-469 (PMID: 11407474)
1 abr | 2001 Beta-catenin expression pattern in small cell lung cancer: correlation with clinical and evolutive features. Rodríguez-Salas, N, Palacios, J, de Castro, J, Moreno, G , González-Barón, M, Gamallo, C . Histol. Histopathol. - 16 (2) : 353-358 (PMID: 11332690)
1 dic | 2000 beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome. de Castro, J, Gamallo, C , Palacios, J, Moreno-Bueno, G , Rodríguez, N, Feliu, J, González-Barón, M. Virchows Arch. - 437 (6) : 599-604 (PMID: 11193470)
15 jul | 2000 Isolation and characterization of casein kinase I from Dictyostelium discoideum. Moreno-Bueno, G , Calés, C , Behrens, MM, Fernández-Renart, M . Biochem. J. - 349 (Pt 2) : 527-537 (PMID: 10880352)
31 ago | 1999 beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Gamallo, C , Palacios, J, Moreno, G , Calvo de Mora, J, Suárez, A, Armas, A. Am. J. Pathol. - 155 (2) : 527-536 (PMID: 10433945)